News Pioneering Crohn’s antibiotic treatment meets early target A drug targeted at treating Crohn’s disease has shown promise following positive results in a phase 3 trial.
News First ever 'off the shelf' stem cell therapy nears European ... Alofisel recommended for complex perianal fistulas in Crohn's disease
News Janssen inks potential $1bn deal for IBD drug Janssen has swooped to buy rights to an early-stage oral inflammatory bowel disease drug from Protagonist Therapeutics in a deal worth up to $1 billion.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
